M7U GER Week ended 07 Aug 2026

Weekly Investor Report

Nynomic AG · Technology · Scientific & Technical Instruments

Open interactive chart View report data
Latest close 16.95 EUR
1.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 12.5% above the Trend Line and sits at 48.3% of its 52-week range. The latest completed week returned 1.8%, after a 5.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.

Setup score 55 out of 100
Latest Close 16.95 EUR 7 Aug 2026
1W Return 1.8% latest completed week
4W Return 5.0% short-term follow-through
12W Return -12.4% quarterly tape
Trend Breadth 34.6% 18 of 52 weeks active
Volume Ratio 2.4x vs 13-week average
What is working
  • The trend backdrop is active with a 18-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 30.54% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.8% Latest completed week; four-week move 5.0%. Indicator stack 64/29 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 30.54% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 2 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.5% above the Trend Line and sits at 48.3% of its 52-week range. The latest completed week returned 1.8%, after a 5.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4512-week average 0.72

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.45Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.0% over four weeks, -12.4% over 12 weeks, and 36.7% over one year. The current trend has remained active for 18 consecutive weeks.

Performance by holding period

1W1.8%
4W5.0%
12W-12.4%
26W69.8%
52W36.7%
Active trend streak18 weeks
Active weeks in one year18
Trend breadth34.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.69Latest activity-pressure read.
Pressure change-111.3%Four-week change in activity pressure.
Leadership19.24Latest relative-leadership reading.
RS change-8.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 85% Model confidence 68%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength25/100Blend of value, momentum, and quality. Underlying universe rank 76; rank 1 is best.
Value30/100Relative valuation strength. Underlying universe rank 71; rank 1 is best.
Quality21/100Profitability and accounting quality. Underlying universe rank 80; rank 1 is best.
Momentum77/100Medium-term price momentum. Underlying universe rank 24; rank 1 is best.
Growth18/100Revenue and earnings growth. Underlying universe rank 83; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
15.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
65.2%
Gross profit retained from each unit of revenue.
Operating margin
1.1%
Operating profit retained from revenue.
Free-cash-flow margin
4.9%
Free cash flow generated from revenue.
Return on invested capital
0.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-9.6%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
15.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.6%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 2 relevant articles.

0 positive · 2 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-35.6%Distance below the 52-week high.
13-week volatility5.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+45.7%Week of 20 Mar.
Worst week-10.0%Week of 15 May.
Latest week+1.8%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains3
Flat weeks0
Modest losses6
Sharp losses10
Recent vol5.8%13-week weekly-return volatility.
Base vol10.3%52-week weekly-return volatility.
Up/down split22/29Count of positive and negative weeks in the 52-week window.
Average skew8.1% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryDE Scientific & Technical Instruments
4-week rank1 / 3
Group average0.7%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD0.0%positive activity pressure
RS100.0%positive relative leadership

Four-week leaders

M7U · GER5.0%V6C · GER3.9%P4O · GER-6.9%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape56/100

Trend, activity pressure, participation, and risk combine to a 56/100 tape read.

 Indicator analysis71/100

Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 12/12.

Activity pressure 0.45; No reversal markers Next-Week ExpectancyNegative 30.54%

Next-week expectancy is negative with a 30.54% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74; Small Cap Core rank 69 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 2 relevant articles.

Nynomic AG: Target Price Consensus and Analysts Recommendations | M7U | DE000A0MSN11 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202616.95 EUR1.8%15.07 EUR20.13 EUR-0.6919.24241.8KOn
31 Jul 202616.65 EUR8.5%14.85 EUR20.24 EUR-0.7320.85138.8KOn
24 Jul 202615.35 EUR-1.9%14.63 EUR20.36 EUR-0.6814.2166.6KOn
17 Jul 202615.65 EUR-3.1%14.44 EUR20.48 EUR-0.5417.9885.8KOn
10 Jul 202616.15 EUR-4.2%14.25 EUR20.60 EUR-0.3320.9860.1KOn
3 Jul 202616.85 EUR-0.6%14.04 EUR20.71 EUR-0.0823.1110.8KOn
26 Jun 202616.95 EUR-6.9%13.85 EUR20.82 EUR0.1529.4229.6KOn
19 Jun 202618.20 EUR-6.9%13.65 EUR20.94 EUR0.4937.5012.6KOn
12 Jun 202619.55 EUR4.0%13.40 EUR21.04 EUR0.7650.4614.5KOn
5 Jun 202618.80 EUR-9.2%13.12 EUR21.15 EUR0.9545.0333.2KOn
29 May 202620.70 EUR-1.4%12.85 EUR21.24 EUR1.2458.37188.2KOn
22 May 202621.00 EUR8.5%12.51 EUR21.34 EUR1.3663.87198.5KOn
15 May 202619.35 EUR-10.0%12.15 EUR21.43 EUR1.5058.76248.8KOn
8 May 202621.50 EUR6.4%11.87 EUR21.52 EUR1.6275.24514.2KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context